Michael M Miazgowicz,1,2 Molly S Elliott,3 Jason S Debley,3 Steven F Ziegler1,21Immunology Program, Benaroya Research Institute, Seattle, WA, 2Department of Immunology, University of Washington School of Medicine, Seattle, WA, 3The Center for Immunology ...
Miazgowicz MM +3 more
doaj
Genetic Variants of Thymic Stromal Lymphopoietin and Non-IgE-Mediated Food Allergy. [PDF]
Coșoreanu MT +8 more
europepmc +1 more source
Serum CitH3 and TSLP as predictive biomarkers for impaired wound healing after bascom cleft lift surgery in pilonidal sinus disease: a nomogram-based risk model. [PDF]
Huo J, Hu B, Lu X, Zhang B, Wang B.
europepmc +1 more source
Tezepelumab: redefining TSLP blockade in severe asthma through mechanistic precision and translational pharmacology. [PDF]
Mansour GK, Kumar S, Sukkarieh HH.
europepmc +1 more source
TSLP‐targeting therapy: Beyond allergy?
Risa Ebina‐Shibuya, Warren J. Leonard
openaire +3 more sources
First-in-human, phase 1 study of CM512, a TSLP/IL-13 bispecific antibody, in healthy volunteers: safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity. [PDF]
Cheng Y +12 more
europepmc +1 more source
Multi-targeted protection of Yuping Tongqiao against allergic rhinitis: suppression of inflammatory response via TSLP signaling and reinforcement of epithelial barrier integrity via AhR signaling. [PDF]
Wang Z +8 more
europepmc +1 more source
Alpha7 nicotinic acetylcholine receptor activation attenuates allergic airway inflammation and is associated with heme oxygenase-1 induction. [PDF]
Iriki J +13 more
europepmc +1 more source
Alterations in the Th2 Profile in a Pediatric Population Exposed to PM Emitted by Agricultural and Industrial Activities: A Cross-Sectional Study. [PDF]
Romo-García MF +17 more
europepmc +1 more source
CM512, a potentially novel IgG1-based bispecific antibody dual-targeting TSLP and IL-13, for the suppression of type 2 inflammation. [PDF]
Yang Y +8 more
europepmc +1 more source

